Deep Vein Thrombosis, Post Thrombotic Syndrome
Conditions
Keywords
Adaptive Compression Therapy Delivery System
Brief summary
This is a two arm, prospective, single center, randomized clinical trial. Subjects will be randomly assigned into one of two groups using block randomization technique in a 1:1 ratio. The control group will receive care using elastic compression stocking and the intervention group will use the ACTitouch device. Stratified randomization will occur based on whether the Deep Vein Thrombosis (DVT) has iliac or non-iliac involvement. Subjects will be followed for 2 years with clinic visits occurring at 1, 3, 6, 12, and 24 months.
Detailed description
The purpose of this study is to determine if use of a pneumatic compression device (ACTitouch, Tactile Medical) is beneficial in improving or preventing the development of Post Thrombotic Syndrome (PTS). 84 patients who have a history of an acute proximal unilateral leg DVT diagnosed one or more months prior to enrollment, or diagnosed with a chronic proximal unilateral leg DVT at time of enrollment, on duplex or other imaging study will be randomized into two groups: the control group receiving the standard of care compression stockings and the intervention group receiving ACTitouch device.
Interventions
DEVICEACTitouch
The device is applied to the lower leg (calf, ankle, and foot) and consists of an under-sock worn against the skin, a compression sleeve containing 4 inflatable chambers and a controller unit. The controller provides the airflow to inflate the chambers and monitors and adjusts the chamber pressure to maintain the intended treatment pressures.
DEVICECompression garments (stockings)
Compression garments (stockings) now serve as the generally recommended standard of care for patients post DVT and will be utilized as the control compression method in this study. Compression garments utilized in this study will be below the knee style with a pressure range of 30-40 mmHg. If a patient does not have compression garments as indicated, these stockings will be provided.
Sponsors
NYU Langone Health
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
subjects who meet the study entrance criteria will be randomly assigned into one of two groups using block randomization technique in a 1:1 ratio. The control group will receive care using elastic compression stocking and the intervention group will use the ACTitouch device. Stratified randomization will occur based on whether the DVT has iliac or non-iliac involvement.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* At least 18 years of age or older * History of an acute proximal unilateral leg DVT diagnosed one or more months prior to enrollment, or diagnosed with a chronic proximal unilateral leg DVT at time of enrollment, on duplex or other imaging study (i.e MRV, CTV, venogram) * Current anticoagulation therapy * Physical ability to independently don ACTitouch or availability of help to place device
Exclusion criteria
* Current diagnosis of PTS or PTS symptoms * Diagnosis of acute DVT less than 30 days prior to enrollment * History of prior ipsilateral DVT * Chronic venous insufficiency (CVI) with a CEAP 4 or greater and/or noted changes in the deep system during the diagnosing duplex * Morbid Obesity (BMI \> 45) * Congestive heart failure with symptoms not controlled by medical intervention * Pulmonary edema, active, with symptoms not controlled by medical intervention * Peripheral artery disease (PAD) unless the patient has an ankle pressure of 60mmHg or more * Walking disability (immobile) * Women who are pregnant or trying to become pregnant * Any other condition in which compression would be contraindicated as determined by the treating physician
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Villalta Score | 2 Years | The Villalta score is a disease score specific for PTS. It can be used to both diagnose and categorize the severity of the condition. It was developed in a cross-sectional study of 100 patients who were assessed 6 to 36 months after DVT. * PTS not present: 0 to 4 * Mild PTS: 5 to 9 * Moderate PTS: 10 to 14 * Severe PTS: \>15 |
Countries
United States
Outcome results
None listed